Products for Research Use Only
RegisterLogin

LJI308

CAT: 0013-GTR19160474-01Size: 200 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19160474-01Size:200 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
LJI308 is a RSK inhibitor. LJI308 overcomes chemoresistance by eliminating cancer stem cells. LJI308 targets the CSC population and repress TNBC growth and dissemination. LJI308 specifically targeted transformed cells as it had little effect on the non-tumorigenic parental HMECs. Targeting RSK using specific and potent inhibitors, such as LJI308, delivers the promise of inhibiting the growth of TNBC.
CAS Number
1627709-94-7
Product Name Alternative
LJI308 | LJI-308 | LJI 308 | NVP-LJI308 | NVP-LJI-308
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 32 mg/mL 86.87 mM
Smiles
Oc1c (F) cc (cc1F) -c1cnccc1-c1ccc (cc1) N1CCOCC1
Molecular Formula
C21H18F2N2O2
Molecular Weight
368.38
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2,6-Difluoro-4-[4-[4- (4-morpholinyl) phenyl]-3-pyridinyl]-phenol

Alternative Products

CatalogName
B6043-25LJI308

Popular Products